In May 2025, she participated in an unusual live sculpture event at Claridge's in London.
Sculptor Frances Segelman created a clay bust of Dench in front of an audience to raise money for lymphoedema research.
Dench could not see the finished sculpture properly.
Still, she attended.
She joked.
She engaged with the audience.
Her daughter Finty Williams took part in the evening.
The Guardian noted that Dench's advanced macular degeneration prevented her from seeing the sculpture being made, yet the event remained filled with humor and creative energy.
And in 2026, Dench remained publicly active.
Sky Arts produced Tea with Judi Dench, including an August 2026 episode in which she sat down with Sir Ian McKellen.
The two old friends discussed life, performance, success, failure and their long careers.
They also laughed a great deal.
Radio Times' August 2026 preview showed something significant: severe sight loss had altered Dench's life, but it had not removed her from conversation, friendship or culture.
What AMD Actually Takes Away
Dench's story also illustrates something frequently misunderstood about macular degeneration.
AMD does not necessarily produce a completely black visual world.
Instead, it primarily attacks central vision.
Someone may still detect light.
They may see movement.
They may perceive the outline of a person.
But the detail in the center — the detail needed to recognize that person's face — may disappear.
That is why Dench can say she sees an outline while simultaneously saying she cannot recognize the individual.
It is also why she can move through some environments with help but cannot read a script.
The condition changes the practical meaning of the word “seeing.”
A person may technically retain vision yet lose many of the visual abilities on which independence depends.
Reading.
Driving.
Recognizing faces.
Watching a film.
Navigating a crowded room.
For an actor, it can mean losing access to the visual cues that make performance possible.
Treatment Has Limits
There are treatments for some forms of AMD, particularly wet AMD.
Anti-VEGF injections can slow or control abnormal blood-vessel growth in many patients and may preserve vision.
But treatment does not always restore sight that has already been lost.
Advanced retinal damage or scarring can become irreversible.
That is an important distinction when discussing Dench's statement that her eyes were beyond treatment.
Her experience does not mean that people diagnosed with AMD have no treatment options.
Early diagnosis and specialist care can be extremely important.
Her case represents advanced disease after more than a decade of progression.
By the end of 2025, British reports citing her Radio Times interview said both eyes had reached a point where further treatment was no longer available to her.
The medical reality therefore makes her long period of continued work even more remarkable.
She did not adapt for a few months.
She adapted for years.
A Career Built on Refusing to Stop
That persistence is consistent with the rest of Judi Dench's career.
She spent much of her early professional life primarily associated with theatre.
At one point, she was even told she did not have the right face for film.
She later became one of the world's most recognizable movie stars.
She became M in the James Bond series at an age when many actresses historically found major film opportunities becoming scarce.
She turned tiny roles into unforgettable ones.
She continued taking challenging work well into her eighties.
And when her vision began failing, she looked for another method.
Friends read scripts.
She memorized by listening.
She relied on assistance.
She learned to navigate sets differently.
She continued until the physical limitations became overwhelming.
Even then, she did not simply disappear.
She redirected her energy.
Interviews.
Books.
Shakespeare.
Educational advocacy.
Charity events.
Conversations with fellow actors.
Public appearances.
Storytelling.
What Remains When the Stage Goes Dark
There is something deeply poignant about an actress gradually losing the ability to see.
Theatre depends on light.
A curtain rises.
Stage lights come on.
An actor looks into another person's eyes.
For Judi Dench, many of those details have faded.
Faces have become fog.
Printed words have disappeared.
Television has become sound.
A script that once could be absorbed visually now has to arrive through somebody else's voice.
But a lifetime of performance has left something behind that AMD cannot easily reach.
Memory.
Dench still carries Shakespeare's words.
She can still talk about how they should be spoken.
She can still tell stories about rehearsals from decades ago.
She can still laugh with Ian McKellen about a career that stretches back more than half a century.
And she can still encourage another generation to encounter the plays that shaped her.
Her response to severe sight loss has therefore not been a simple story of triumph over adversity.
Dench herself would probably reject anything so neat.
She has described the condition as devastating.
She has admitted what she misses.
She has acknowledged that traditional acting is no longer realistically available in the way it once was.
“It’s a crusher” is not the language of someone pretending that everything is fine.
It is the language of someone acknowledging a profound loss.
But loss is not the same as disappearance.
At 91, Judi Dench remains Judi Dench.
The actress who played Lady Macbeth may no longer be able to read the play.
The woman who commanded James Bond may need someone's arm to navigate a public event.
One of the most recognizable faces in Britain may sometimes greet strangers because she cannot recognize theirs.
There is humor in that.
There is sadness in it too.
And there is something extraordinary about the fact that, when the visual world has become increasingly indistinct, the words remain.
Lines learned fifty or sixty years ago are still there.
Shakespeare is still there.
The stories are still there.
And so is she.
Sources and Fact-Checking
This expanded account draws on Judi Dench's late-2025 interviews with Radio Times and ITV, as reported by RTÉ, The Independent, The Guardian, AFP and other established outlets; earlier interviews in which Dench discussed learning scripts through listening and relying on friends; and material from the Royal Shakespeare Company about her continuing involvement with Shakespeare and education.
The medical explanation of age-related macular degeneration is consistent with information from major ophthalmic authorities: AMD damages central vision rather than necessarily causing total blindness, and advanced disease can severely impair reading and facial recognition.
Reports based on Dench's December 2025 Radio Times interview stated that both of her eyes had reached an advanced stage considered beyond further treatment. This refers specifically to the progression of Dench's individual condition and should not be interpreted to mean that AMD in general is untreatable. Some forms, particularly wet AMD, can be managed with treatments such as anti-VEGF injections when medically appropriate.
Dench turned 91 on December 9, 2025. As of 2026, she has continued to make public and media appearances, including Tea with Judi Dench, demonstrating that severe vision loss has largely curtailed conventional acting but has not ended her involvement in cultural life.